Hill, J A
Boeckh, M
Leisenring, W M
Xie, H
Adler, A L
Huang, M-L
Fann, J R
Delaney, C
Zerr, D M
Article History
Received: 17 February 2015
Revised: 10 April 2015
Accepted: 2 May 2015
First Online: 29 June 2015
Competing interests
: MB received research funding for clinical trials and consulting fees from Chimerix Inc., Genentech/Roche and Gilead in addition to consulting for Clinigen. DMZ received research funding from Chimerix Inc. All other authors report no potential conflicts.